Aquapharm's R&D is focused on developing new and
commercially valuable products derived from marine
The company's discovery process combines microbiology, screening
and natural product chemistry to provide a robust platform for the
discovery of novel compounds and bioactives for future use as novel
anti-inflammatory, tissue-protective and antibiotic drugs and
functional ingredients for the personal care and food and beverage
All of Aquapharm's research and development is conducted to the
highest scientific quality standards. Extracts are screened in
vitro against cell-based assays as an effective and rapid
method of identifying novel compounds.
Aquapharm uses a range of induction technologies and culturing
methodologies, including its proprietary screening technology,
SeaRch™, to gain access to the full spectrum of bio-active
compounds that the marine microbes in its collection can produce.
These technologiesunlock the evolutionary legacy of these microbes'
chemical arsenals revealing a wider array of metabolites of
interest than has traditionally been possible.